Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm?

Gynecologic Oncology

Volumn 125, Issue 2, 2012, Pages 285-286

  Rose, Peter G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; EARLY CANCER; EDITORIAL; HUMAN; HYSTERECTOMY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84859606046     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.010     Document Type: Editorial

References (10)

1. Galic V, Herzog TJ, Lewin SN, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 2012;125(2):287-91.
2. Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S, Sasajima Y, et al. Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. Br J Cancer May 5 2009;100(9):1400-5.
3. Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol 2012;125(2):292-6.
4. Tsukahara Y, Sakai Y, Noguchi H, Iwai S, Fukuta T. A study on radiosensitivity and prognostic factors of cervical adenocarcinoma. Nihon Sanka Fujinka Gakkai Zasshi Oct 1980;32(10):1609-14. (Pubitemid 11214101)
5. Moyses HM, Morrow CP, Muderspach LI, Roman LD, Vasilev SA, Petrovich Z, et al. Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma. Am J Clin Oncol 1996 Oct;19(5):433-8. (Pubitemid 26314869)
6. Steel GG. Growth kinetics of tumors: cell population kinetics in relation to the growth and treatment of cancer. Oxford, England: Clarendon Press; 1977.
7. West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys Feb 15 1995;31(4):841-6.
8. Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, et al. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys Jun 1 2011;80(2): 429-36 Epub 2010 Jun 9.
9. Peters III WA, Liu PY, Barrett II RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol Apr 2000;18(8):1606-13. (Pubitemid 30220538)
10. Tang J, Tang Y, Yang J, Huang S. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma. Gynecol Oncol 2012;125(2):297-302.